Stwardnienie rozsiane
Diagnostyka i diagnoza
Diagnostyka stwardnienia rozsianego (SM) opiera się na spełnieniu kryteriów McDonalda 2017, które wymagają wykazania rozsiewu zmian demielinizacyjnych w ośrodkowym układzie nerwowym (OUN) w przestrzeni (DIS) i czasie (DIT), przy jednoczesnym wykluczeniu innych schorzeń. Kluczową rolę odgrywa rezonans magnetyczny (MRI), umożliwiający identyfikację ognisk demielinizacyjnych w mózgu i rdzeniu kręgowym, z uwidocznieniem aktywnych zmian po podaniu kontrastu gadolinowego. Około 90% pacjentów z SM wykazuje nieprawidłowości w MRI, a obecność zarówno wzmacniających, jak i niewzmacniających się zmian pozwala na postawienie diagnozy już po pierwszym rzucie choroby. Analiza płynu mózgowo-rdzeniowego (PMR) wykazuje prążki oligoklonalne u 75-85% chorych oraz podwyższony indeks IgG, co może zastąpić kryterium rozsiewu w czasie u pacjentów z pierwszym izolowanym zespołem objawów (CIS). Badania potencjałów wywołanych (VEP, SSEP, BAEP) dostarczają dodatkowych dowodów na subkliniczne uszkodzenia dróg nerwowych, często wykrywając zmiany niewidoczne w badaniu neurologicznym.
- Diagnostyka stwardnienia rozsianego
- Metody diagnostyczne w rozpoznawaniu stwardnienia rozsianego
- Rezonans magnetyczny (MRI)
- Badanie płynu mózgowo-rdzeniowego
- Badania potencjałów wywołanych
- Badania krwi
- Badanie neurologiczne
- Diagnostyka różnicowa
- Wyzwania diagnostyczne
- Nowe kierunki w diagnostyce stwardnienia rozsianego
- Znaczenie wczesnej diagnozy
- Podsumowanie procesu diagnostycznego stwardnienia rozsianego
Diagnostyka stwardnienia rozsianego
Nie istnieje pojedynczy test diagnostyczny, który mógłby definitywnie potwierdzić rozpoznanie stwardnienia rozsianego (SM, łac. sclerosis multiplex). Diagnoza opiera się na kombinacji objawów klinicznych, badania neurologicznego i badań dodatkowych, które razem muszą wykazać uszkodzenia ośrodkowego układu nerwowego (OUN) rozproszone w czasie i przestrzeni, przy jednoczesnym wykluczeniu innych schorzeń o podobnym obrazie klinicznym123.
Kryteria diagnostyczne McDonalda
Obecnie powszechnie stosowanymi kryteriami diagnostycznymi są kryteria McDonalda, które zostały zaktualizowane w 2017 roku. Kryteria te umożliwiają wcześniejsze i dokładniejsze rozpoznanie SM poprzez wykorzystanie dowodów klinicznych, laboratoryjnych i radiologicznych dotyczących zmian w różnych obszarach i w różnym czasie45. Aby postawić diagnozę stwardnienia rozsianego zgodnie z tymi kryteriami, muszą zostać spełnione następujące warunki:
- Wykazanie rozsiewu zmian w przestrzeni (DIS – dissemination in space) – czyli obecności zmian demielinizacyjnych w co najmniej dwóch różnych obszarach ośrodkowego układu nerwowego6.
- Wykazanie rozsiewu zmian w czasie (DIT – dissemination in time) – czyli pojawienia się nowych zmian w różnych odstępach czasu7.
- Wykluczenie innych potencjalnych przyczyn objawów i zmian w OUN8.
Metody diagnostyczne w rozpoznawaniu stwardnienia rozsianego
Rezonans magnetyczny (MRI)
Rezonans magnetyczny jest obecnie najważniejszym narzędziem diagnostycznym w procesie rozpoznawania stwardnienia rozsianego. MRI pozwala na wizualizację zmian demielinizacyjnych w mózgu i rdzeniu kręgowym, które są charakterystyczne dla SM910. Badanie to umożliwia:
- Identyfikację plak (ognisk demielinizacyjnych) typowych dla SM w różnych obszarach OUN11.
- Rozróżnienie między starymi a nowymi zmianami, szczególnie przy zastosowaniu kontrastu gadolinowego, który uwidacznia aktywne ogniska zapalne12.
- Wykazanie rozsiewu zmian w przestrzeni i czasie, co jest kluczowe dla diagnozy13.
Około 90% pacjentów z SM ma nieprawidłowości widoczne w badaniu MRI14. W przypadku typowego obrazu klinicznego i radiologicznego, diagnoza może zostać postawiona już po pierwszym rzucie choroby, jeśli w badaniu MRI widoczne są zarówno wzmacniające się, jak i niewzmacniające się po podaniu kontrastu zmiany, co sugeruje ich różny wiek15.
Badanie płynu mózgowo-rdzeniowego
Analiza płynu mózgowo-rdzeniowego (PMR) uzyskanego za pomocą nakłucia lędźwiowego (punkcji lędźwiowej) może dostarczyć dodatkowych dowodów na obecność przewlekłego stanu zapalnego w ośrodkowym układzie nerwowym2″>16. Kluczowe zmiany obserwowane w PMR w stwardnieniu rozsianym to:
- Obecność prążków oligoklonalnych (oligoclonal bands) – występują one u 75-85% pacjentów z SM. Są to specyficzne przeciwciała produkowane w ośrodkowym układzie nerwowym, które nie są obecne w surowicy krwi1718.
- Podwyższony indeks IgG lub zwiększona synteza IgG19.
- Umiarkowana pleocytoza (zwiększona liczba komórek).
Zgodnie z zaktualizowanymi kryteriami McDonalda z 2017 roku, obecność prążków oligoklonalnych w PMR może zastąpić kryterium rozsiewu w czasie u pacjentów z pierwszym izolowanym zespołem objawów klinicznych (CIS), którzy spełniają kryterium rozsiewu w przestrzeni20. Oznacza to, że diagnoza SM może zostać postawiona wcześniej, bez konieczności oczekiwania na pojawienie się nowych zmian w kontrolnym badaniu MRI21.
Badania potencjałów wywołanych
Badania potencjałów wywołanych (EP – evoked potentials) rejestrują odpowiedź elektryczną układu nerwowego na stymulację specyficznych dróg czuciowych22. Te badania mogą wykazać subkliniczne uszkodzenia dróg nerwowych, które nie są jeszcze widoczne w badaniu neurologicznym. W diagnostyce SM wykorzystuje się najczęściej:
- Wzrokowe potencjały wywołane (VEP) – oceniają przewodnictwo w drodze wzrokowej; często wykazują nieprawidłowości nawet u pacjentów bez objawów ocznych, przez co są uznawane za najbardziej przydatne w potwierdzaniu diagnozy SM2324.
- Somatosensoryczne potencjały wywołane (SSEP) – badają przewodnictwo w drogach czuciowych.
- Słuchowe potencjały wywołane pnia mózgu (BAEP) – oceniają przewodnictwo w drodze słuchowej.
Badania potencjałów wywołanych są często bardziej czułe niż objawy kliniczne i mogą dostarczyć obiektywnych dowodów na obecność zmian demielinizacyjnych w OUN25.
Badania krwi
Chociaż nie istnieje specyficzny test krwi, który mógłby potwierdzić diagnozę stwardnienia rozsianego, badania krwi są ważną częścią procesu diagnostycznego, gdyż pozwalają wykluczyć inne choroby o podobnym obrazie klinicznym2627. Badania te mogą obejmować:
- Morfologię krwi
- Badania biochemiczne
- Poziom witaminy B12
- Testy funkcji tarczycy
- Markery zapalne
- Badania serologiczne w kierunku chorób infekcyjnych (np. borelioza, HIV)
- Badania przeciwciał w kierunku chorób autoimmunologicznych (np. toczeń, zespół Sjögrena)
- Specyficzne przeciwciała charakterystyczne dla zaburzeń ze spektrum zapalenia nerwów wzrokowych i rdzenia (NMOSD) – przeciwciała anty-AQP4 i przeciwciała anty-MOG2829.
Badanie neurologiczne
Dokładne badanie neurologiczne jest niezbędne w procesie diagnostycznym stwardnienia rozsianego30. Pozwala ono na ocenę funkcji różnych obszarów układu nerwowego i może ujawnić objawy odpowiadające uszkodzeniom w różnych lokalizacjach OUN. Podczas badania neurologicznego oceniane są:
- Funkcje nerwów czaszkowych, w tym ostrość wzroku i pola widzenia
- Siła mięśniowa
- Odruchy
- Czucie
- Koordynacja ruchowa
- Równowaga
- Funkcje poznawcze
Wyniki badania neurologicznego w połączeniu z wywiadem medycznym mogą dostarczyć wystarczających dowodów na spełnienie kryteriów diagnostycznych, szczególnie w przypadku typowego przebiegu klinicznego31.
Diagnostyka różnicowa
Ważnym elementem procesu diagnostycznego jest wykluczenie innych chorób, które mogą dawać podobne objawy jak stwardnienie rozsiane32. Lista potencjalnych rozpoznań różnicowych jest obszerna i może obejmować:
- Ostre rozsiane zapalenie mózgu i rdzenia (ADEM)33
- Zespoły ze spektrum zapalenia nerwów wzrokowych i rdzenia (NMOSD)34
- Choroby naczyniowe mózgu, w tym CADASIL35
- Choroby infekcyjne (borelioza, HIV, PML)36
- Inne choroby autoimmunologiczne (toczeń, sarkoidoza, zespół Sjögrena)37
- Choroby metaboliczne (niedobór witaminy B12)38
- Nowotwory ośrodkowego układu nerwowego39
Wykluczenie tych chorób jest kluczowe, ponieważ błędne rozpoznanie SM może prowadzić do wdrożenia niewłaściwego leczenia, które nie tylko nie przyniesie poprawy, ale może być potencjalnie szkodliwe dla pacjenta40.
Wyzwania diagnostyczne
Diagnoza stwardnienia rozsianego może być trudna z kilku powodów:
Niespecyficzne objawy
Objawy SM mogą być bardzo różnorodne i często przypominają inne choroby41. Wczesne objawy, takie jak zmęczenie, zaburzenia czucia czy problemy z widzeniem, mogą być łatwo przypisane innym przyczynom42.
Zmienność kliniczna
Przebieg choroby jest różny u różnych pacjentów, a początkowe objawy mogą być subtelne i przejściowe43. U niektórych pacjentów może wystąpić tylko jeden epizod objawów, co utrudnia spełnienie kryteriów rozsiewu w czasie44.
Niespecyficzne zmiany w MRI
Choć MRI jest niezwykle przydatnym narzędziem diagnostycznym, małe zmiany hiperintensywne w obrazach T2-zależnych (tzw. UBOs – unidentified bright objects) są stosunkowo częste w populacji ogólnej i mogą być błędnie interpretowane jako zmiany demielinizacyjne45.
Ryzyko błędnej diagnozy
Badania wskazują, że nawet do 20% pacjentów skierowanych do ośrodków specjalizujących się w leczeniu SM z rozpoznaniem tej choroby w rzeczywistości cierpi na inne schorzenia4647. Błędne rozpoznanie może wynikać z nieprawidłowej interpretacji objawów klinicznych lub zmian w badaniach obrazowych48.
Nowe kierunki w diagnostyce stwardnienia rozsianego
Naukowcy i klinicyści nieustannie poszukują nowych metod, które mogłyby ułatwić wczesną i dokładną diagnozę stwardnienia rozsianego. Obiecujące kierunki badań obejmują:
Zaawansowane techniki obrazowania
- Objaw centralnej żyły (central vein sign) – obecność zmiany demielinizacyjnej wokół żyły centralnej jest wysoce specyficzna dla SM i może pomóc w odróżnieniu zmian związanych z SM od innych zmian w istocie białej49.
- Spektroskopia rezonansu magnetycznego (MRS) – pozwala na pomiar biochemicznych składników tkanki mózgowej, w tym N-acetyloasparaginianu, którego poziom jest obniżony w SM50.
- Obrazowanie transferu magnetyzacji (MTI) – może wykrywać subtelne zmiany w tkance mózgowej, niewidoczne w standardowym MRI.
Biomarkery krwi
Trwają intensywne badania nad identyfikacją biomarkerów we krwi, które mogłyby ułatwić diagnozę SM51. Obiecujące wyniki dotyczą:
- Lekkie łańcuchy neurofilamentów (NfL) – białka uwalniane do krwi przy uszkodzeniu neuronów52.
- Kwaśne białko włókienkowe gleju (GFAP) – marker uszkodzenia astrocytów53.
- Autoprzeciwciała – np. przeciwko receptorowi serotoninowemu typu 2A, które wykazują wysoką czułość i swoistość w diagnozie SM54.
- Agregaty immunoglobulin G (IgG) – badania wskazują, że mogą być wykrywane we wczesnych stadiach SM z dużą dokładnością i korelują z progresją choroby55.
Niedawne odkrycie sugeruje, że u około 10% pacjentów z SM organizm zaczyna produkować charakterystyczny zestaw autoprzeciwciał przeciwko własnym białkom na lata przed pojawieniem się objawów, co może w przyszłości umożliwić wcześniejszą diagnozę i leczenie5657.
Badanie optycznej koherentnej tomografii (OCT)
OCT jest nieinwazyjną metodą obrazowania, która pozwala na ocenę grubości warstw siatkówki. Zanik warstwy włókien nerwowych siatkówki może być wczesnym markerem neurodegeneracji w SM5859.
Znaczenie wczesnej diagnozy
Wczesna diagnoza stwardnienia rozsianego ma kluczowe znaczenie z kilku powodów:
- Pozwala na wczesne rozpoczęcie leczenia modyfikującego przebieg choroby (DMT), co może spowolnić postęp choroby i opóźnić rozwój niepełnosprawności6061.
- Zmniejsza niepewność pacjenta i pozwala mu zaakceptować diagnozę oraz dostosować się do życia z przewlekłą chorobą62.
- Umożliwia pacjentowi dostęp do odpowiednich zasobów medycznych i wsparcia63.
- Zapobiega trwałemu uszkodzeniu neurologicznemu, które może wystąpić nawet we wczesnych stadiach choroby64.
Podsumowanie procesu diagnostycznego stwardnienia rozsianego
Diagnoza stwardnienia rozsianego jest złożonym procesem wymagającym doświadczenia klinicznego, szczegółowej oceny objawów i wyników badań dodatkowych. Kluczowe elementy tego procesu obejmują:
- Dokładny wywiad medyczny i badanie neurologiczne.
- Badanie rezonansu magnetycznego mózgu i rdzenia kręgowego.
- Badanie płynu mózgowo-rdzeniowego (w wybranych przypadkach).
- Badania potencjałów wywołanych (w wybranych przypadkach).
- Badania krwi w celu wykluczenia innych chorób.
- Ocenę spełnienia kryteriów McDonalda (rozsiew w czasie i przestrzeni).
- Wykluczenie innych potencjalnych przyczyn objawów.
Należy pamiętać, że diagnoza stwardnienia rozsianego powinna być postawiona przez doświadczonego neurologa, najlepiej specjalizującego się w chorobach demielinizacyjnych, który potrafi właściwie zinterpretować wyniki badań w kontekście obrazu klinicznego pacjenta6566.
Mimo że proces diagnostyczny może być czasochłonny i stresujący dla pacjenta, dokładna diagnoza jest niezbędna do wdrożenia odpowiedniego leczenia, które może znacząco wpłynąć na dalszy przebieg choroby i jakość życia pacjenta67.
Kolejne rozdziały
Zapraszamy do dalszego czytania naszego leksykonu.
Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.
Materiały źródłowe
- #1 Clinical presentation and diagnosis of multiple sclerosishttps://pmc.ncbi.nlm.nih.gov/articles/PMC7385797/
The diagnosis of multiple sclerosis (MS) is through clinical assessment and supported by investigations. There is no single accurate and reliable diagnostic test. […] The diagnosis of multiple sclerosis is a clinical diagnosis supported by investigation findings. There is no single sensitive and specific diagnostic test for multiple sclerosis. […] The diagnosis of MS is based on the clinical features of the attacks including the history and examination findings. The guiding principle of the diagnosis is that of dissemination in time (DIT) and dissemination in space (DIS). There is no single diagnostic laboratory test for MS. The diagnosis is based on the clinical findings supported by investigations. […] The diagnosis of MS is still based on a combination of clinical, MRI and laboratory (eg CSF) findings. The diagnostic criteria are designed to be used for patients with typical clinical presentations and should not be applied in cases where MRI changes are incidentally identified in asymptomatic individuals. […] The aim of the criteria is to make an earlier and accurate diagnosis of MS and lessen the period of uncertainty for the patient and clinician. This enables appropriate management including confirmation of the diagnosis for the patient and access to effective disease modifying treatments.
- #2 Multiple sclerosis – Diagnosis and treatment – Mayo Clinichttps://www.mayoclinic.org/diseases-conditions/multiple-sclerosis/diagnosis-treatment/drc-20350274
A complete neurological exam and medical history are needed to diagnose MS. […] There are no specific tests for MS. The diagnosis is given by a combination of medical history, physical exam, MRIs and spinal tap results. A diagnosis of multiple sclerosis also involves ruling out other conditions that might produce similar symptoms. This is known as a differential diagnosis. […] In most people with relapsing-remitting MS, the diagnosis is straightforward. Diagnosis is based on a pattern of symptoms related to MS and confirmed by test results. […] Diagnosing MS can be harder in people with unusual symptoms or progressive disease. Additional testing may be needed.
- #3 How Is Multiple Sclerosis Diagnosed? | National MS SocietyNational Multiple Sclerosis Society LogoNational Multiple Sclerosis Society LogoOpen searchhttps://www.nationalmssociety.org/understanding-ms/what-is-ms/how-ms-is-diagnosed
At this time, no symptoms, physical findings or laboratory tests can, by themselves, prove that you have multiple sclerosis. To make an MS diagnosis, the physician must: […] This is the long-established criteria for an MS diagnosis. The McDonald Criteria spells out these criteria and the guidelines for establishing them. The International Panel on the Diagnosis of Multiple Sclerosis published this in 2017. […] Doctors may use many methods to decide if you meet the criteria for an MS diagnosis, including: […] Cerebrospinal fluid analysis (CSF), or spinal tap, is used to look for a group of proteins called oligoclonal bands. They may use this analysis instead of dissemination in time. It is important to know that an abnormal immune response in the CSF is found in other diseases, so the test is not specific for MS. In people with a confirmed diagnosis of MS, 5%-10% do not show abnormalities in the CSF. Therefore, CSF analysis by itself cannot confirm or exclude an MS diagnosis.
- #4 Multiple sclerosis – Wikipediahttps://en.wikipedia.org/wiki/Multiple_sclerosis
Multiple sclerosis is typically diagnosed based on the presenting signs and symptoms, in combination with supporting medical imaging and laboratory testing. It can be difficult to confirm, especially early on, since the signs and symptoms may be similar to those of other medical problems. […] The McDonald criteria, which focus on clinical, laboratory, and radiologic evidence of lesions at different times and in different areas, is the most commonly used method of diagnosis with the Schumacher and Poser criteria being of mostly historical significance. […] The McDonald criteria states that patients with multiple sclerosis should have lesions which are disseminated in time (DIT) and disseminated in space (DIS), i.e. lesions which have appeared in different areas in the brain and at different times.
- #5 Diagnosis of multiple sclerosis – Wikipediahttps://en.wikipedia.org/wiki/Diagnosis_of_multiple_sclerosis
Current standards for diagnosing multiple sclerosis (MS) are based on the 2018 revision of McDonald criteria. They rely on MRI detection (or clinical demonstration) of demyelinating lesions in the CNS, which are distributed in space (DIS) and in time (DIT). […] The McDonald criteria, which focus on clinical, laboratory, and radiologic evidence of lesions at different times and in different areas, is the most commonly used method of diagnosis. […] Clinical data alone may be sufficient for a diagnosis of MS if an individual has had separate episodes of neurologic symptoms characteristic of the disease. […] The most commonly used diagnostic tools are neuroimaging, analysis of cerebrospinal fluid and evoked potentials. […] Testing of cerebrospinal fluid obtained from a lumbar puncture can provide evidence of chronic inflammation in the central nervous system.
- #6 Learn About Multiple Sclerosis | Shepherd Centerhttps://shepherd.org/treatment/conditions/multiple-sclerosis/overview/
Multiple sclerosis (MS) cannot be diagnosed with a specific symptom or single lab test. Instead, physicians rely on several strategies and diagnostic tests to confidently make a diagnosis and rule out other possible conditions. Diagnosing MS quickly and accurately is important as neurologic damage can occur in the early stages of MS. […] A set of diagnostic parameters, known as the McDonald Criteria, makes the process easier and more efficient in diagnosing MS in new patients. To fulfill a definite diagnosis of MS, an individual must have met the following criteria: Evidence of damage in at least two separate areas of the central nervous system (CNS), including the brain, spinal cord, and optic nerves. Evidence of damage occurring at least one month apart. All other possible diagnoses have been ruled out.
- #7 Learn About Multiple Sclerosis | Shepherd Centerhttps://shepherd.org/treatment/conditions/multiple-sclerosis/overview/
Multiple sclerosis (MS) cannot be diagnosed with a specific symptom or single lab test. Instead, physicians rely on several strategies and diagnostic tests to confidently make a diagnosis and rule out other possible conditions. Diagnosing MS quickly and accurately is important as neurologic damage can occur in the early stages of MS. […] A set of diagnostic parameters, known as the McDonald Criteria, makes the process easier and more efficient in diagnosing MS in new patients. To fulfill a definite diagnosis of MS, an individual must have met the following criteria: Evidence of damage in at least two separate areas of the central nervous system (CNS), including the brain, spinal cord, and optic nerves. Evidence of damage occurring at least one month apart. All other possible diagnoses have been ruled out.
- #8 Learn About Multiple Sclerosis | Shepherd Centerhttps://shepherd.org/treatment/conditions/multiple-sclerosis/overview/
Multiple sclerosis (MS) cannot be diagnosed with a specific symptom or single lab test. Instead, physicians rely on several strategies and diagnostic tests to confidently make a diagnosis and rule out other possible conditions. Diagnosing MS quickly and accurately is important as neurologic damage can occur in the early stages of MS. […] A set of diagnostic parameters, known as the McDonald Criteria, makes the process easier and more efficient in diagnosing MS in new patients. To fulfill a definite diagnosis of MS, an individual must have met the following criteria: Evidence of damage in at least two separate areas of the central nervous system (CNS), including the brain, spinal cord, and optic nerves. Evidence of damage occurring at least one month apart. All other possible diagnoses have been ruled out.
- #9 Multiple Sclerosis (MS) Diagnosis: How Doctors Test for MShttps://www.webmd.com/multiple-sclerosis/multiple-sclerosis-diagnosing
There’s no single test that can tell whether you have multiple sclerosis (MS), so it may take some time and multiple doctor visits to get a diagnosis. Doctors use a combination of physical exams, medical history questions, imaging tests, and laboratory tests to diagnose the condition. […] Your doctor may suspect you have MS if you have symptoms like: Numbness or tingling in your skin (usually in your hands or feet), Unusual weakness in your arms, legs, or fingers, Slurred speech, Stumbling or trouble walking, Double vision or loss of color, Flashing lights that others can’t see, Eye pain that gets worse when you move. […] If your symptoms, medical history, and physical exam results point to MS, your doctor can order one or more tests to help them tell whether your brain and spinal cord are working as they should.
- #10 Learn About Multiple Sclerosis | Shepherd Centerhttps://shepherd.org/treatment/conditions/multiple-sclerosis/overview/
The first step in diagnosing the disease is thoroughly reviewing your medical history. During this time, your healthcare provider will gather information about birthplace, family history, environmental exposures, and other illnesses that may meet any risk factors for MS. […] Along with your medical history, a physical and neurological exam is used to confirm MS symptoms while testing the nerves that control your vision, strength, and hearing. […] The medical history and exam can often provide enough evidence to meet the diagnostic criteria. However, additional testing may be necessary to confirm the diagnosis further or rule out other conditions that may cause symptoms like MS. […] An MRI is the best imaging technology to detect scarring or MS plaques in different parts of the central nervous system (CNS). This test can also distinguish old MS plaques from those currently active or new ones.
- #11 4 Common Diagnostic Tools Used To Prove or Disprove MS | CNS Westhttps://www.cnsnevada.com/4-common-diagnostic-tools-used-to-prove-or-disprove-ms/
The 4 common diagnostic tools used to prove or disprove MS â multiple sclerosis by clinical neurologists are: A comprehensive patient medical history and neurological exam. Magnetic resonance imaging of the neuroaxis. Evoked Potentials testing. Analysis of the spinal fluid. […] There is no single test that can be used to definitively diagnose a person with MS. Diagnosis involves both clinical evidence (something that a doctor observes during a neurological examination, or learns from a patientâs history) and the results of certain tests, such as MRI, spinal tap, or evoked potentials. […] In many instances, medical history and neurologic exam provide enough evidence to meet the diagnostic criteria. Other tests are used to confirm the diagnosis or to identify other possible causes of the symptoms or neurological exam findings.
- #12 Learn About Multiple Sclerosis | Shepherd Centerhttps://shepherd.org/treatment/conditions/multiple-sclerosis/overview/
The first step in diagnosing the disease is thoroughly reviewing your medical history. During this time, your healthcare provider will gather information about birthplace, family history, environmental exposures, and other illnesses that may meet any risk factors for MS. […] Along with your medical history, a physical and neurological exam is used to confirm MS symptoms while testing the nerves that control your vision, strength, and hearing. […] The medical history and exam can often provide enough evidence to meet the diagnostic criteria. However, additional testing may be necessary to confirm the diagnosis further or rule out other conditions that may cause symptoms like MS. […] An MRI is the best imaging technology to detect scarring or MS plaques in different parts of the central nervous system (CNS). This test can also distinguish old MS plaques from those currently active or new ones.
- #13 What is the diagnosis of multiple sclerosis (MS)? | Paris Brain Institutehttps://parisbraininstitute.org/disease-files/multiple-sclerosis-ms/what-diagnosis-multiple-sclerosis-ms
The diagnosis of MS is based on a combination of neurological symptoms associated with inflammatory plaques on MRI that respond to spatial dissemination (brain, spinal cord, optic nerve) and temporal dissemination (inflammatory plaques of different ages or that appear over time). […] The diagnosis of MS is based on MRI observation of inflammatory plaques visible by hypersignalling in the brain and spinal cord spread over time (recent and old lesions) and space (lesions involving at least two regions between 4 possible locations in the central nervous system).
- #14 Azthena logo with the word Azthenahttps://www.news-medical.net/health/Multiple-Sclerosis-Diagnosis.aspx
The majority (90%) of individuals with MS have their condition confirmed using MRI. […] This cerebrospinal fluid (CSF) is tested for antibodies, the presence of which indicates that the immune system has been attacking the nervous system. […] A lumbar test is usually only performed if other tests for MS have not been able to confirm the diagnosis. […] For this test, electrodes are applied to the patients head to monitor the brains responses to visual and auditory stimulation and show whether nerve transmission is occurring normally. […] Blood test are run to check for any alternative causes of symptoms. […] Once an MS diagnosis is confirmed, the neurologist can identify which form of MS a patient has, although the patients may need to be monitored for some time before this can be decided.
- #15 Multiple Sclerosis (MS) – Neurologic Disorders – Merck Manual Professional Editionhttps://www.merckmanuals.com/professional/neurologic-disorders/demyelinating-disorders/multiple-sclerosis-ms
Multiple sclerosis is suspected in patients with optic neuritis, internuclear ophthalmoplegia, or other symptoms that suggest MS, particularly if deficits are multifocal or intermittent. If MS is suspected, brain MRI and spinal MRI are done. […] MRI is the most sensitive imaging test for MS and can exclude other treatable disorders that may mimic MS, such as nondemyelinating lesions at the junction of the spinal cord and medulla (eg, subarachnoid cyst, foramen magnum tumors). Gadolinium-contrast enhancement can distinguish actively inflamed from older plaques. Also, higher-field MRI magnets (3 to 7 Tesla) can distinguish perivenular MS plaques from nonspecific white-matter lesions. […] MS can be distinguished because diagnosis of MS requires evidence of CNS lesions that are separated in both time and space (location in the CNS). For example, any of the following can indicate separation in time: A history of exacerbations and remissions, MRI that shows simultaneous enhancing and nonenhancing lesions, even if patients are asymptomatic, a new lesion on a subsequent MRI in patients with a previous lesion.
- #17 Multiple sclerosis – Wikipediahttps://en.wikipedia.org/wiki/Multiple_sclerosis
As of 2017, no single test (including biopsy) can provide a definitive diagnosis. […] Magnetic resonance imaging (MRI) of the brain and spine may show areas of demyelination (lesions or plaques). […] Testing of cerebrospinal fluid obtained from a lumbar puncture can provide evidence of chronic inflammation in the central nervous system. The cerebrospinal fluid is tested for oligoclonal bands of IgG on electrophoresis, which are inflammation markers found in 75-85% of people with MS. […] Several diseases present similarly to MS. Medical professionals use a patient’s specific presentation, history, and exam findings to make an individualized differential.
- #18 Diagnosis of multiple sclerosis – Wikipediahttps://en.wikipedia.org/wiki/Diagnosis_of_multiple_sclerosis
Current standards for diagnosing multiple sclerosis (MS) are based on the 2018 revision of McDonald criteria. They rely on MRI detection (or clinical demonstration) of demyelinating lesions in the CNS, which are distributed in space (DIS) and in time (DIT). […] The McDonald criteria, which focus on clinical, laboratory, and radiologic evidence of lesions at different times and in different areas, is the most commonly used method of diagnosis. […] Clinical data alone may be sufficient for a diagnosis of MS if an individual has had separate episodes of neurologic symptoms characteristic of the disease. […] The most commonly used diagnostic tools are neuroimaging, analysis of cerebrospinal fluid and evoked potentials. […] Testing of cerebrospinal fluid obtained from a lumbar puncture can provide evidence of chronic inflammation in the central nervous system.
- #19 Multiple Sclerosis (MS) – Neurologic Disorders – Merck Manual Professional Editionhttps://www.merckmanuals.com/professional/neurologic-disorders/demyelinating-disorders/multiple-sclerosis-ms
CSF examination is being done less frequently (because the diagnosis can usually be based on MRI) but can be helpful if MRI plus clinical findings are inconclusive or if infection (eg, CNS Lyme disease) must be ruled out. CSF tests include opening pressure, cell count and differential, protein, glucose, IgG, oligoclonal bands, and usually myelin basic protein and albumin. […] MS must be distinguished from clinically isolated syndromes (consisting of only a single clinical manifestation typical of MS) and radiologically isolated syndrome (MRI findings typical of MS that are incidentally noted in patients with no clinical manifestations).
- #20 Diagnosing Multiple Sclerosis Using the McDonald Criteria – Multiple Sclerosis Centers of Excellencehttps://www.va.gov/MS/Professionals/diagnosis/Diagnosing_MS_Using_the_McDonald_Criteria.asp
An MRI has the ability to show dissemination in space with lesions in typical locations, and dissemination in time with the presence of simultaneous enhancing and non-enhancing lesions, or new lesion formation on a subsequent MRI. Consensus recommendations are to use brain MRI with and without contrast for initial diagnosis (Filippi 2016). Spinal cord imaging is indicated if the clinical exam localizes to the spinal cord, or the brain MRI does not demonstrate dissemination in space. The whole cord (cervical through lumbar) spinal cord imaging is advised with and without contrast, however the bulk of the cord lesions occur in the cervical and thoracic cord. […] Additional testing for the diagnosis of MS may be necessary, including blood tests and spinal fluid analysis. Elevated CSF oligoclonal bands, an elevated IgG index, and/or IgG synthetic rate is found in about 75% of people with MS. In patients with one clinical attack and evidence on two or more typical lesions on MRI, the presence of oligoclonal bands can establish dissemination in time (and thus a diagnosis of MS) with the 2017 McDonald Criteria. There is no one laboratory, MRI, or clinical test that definitively rules in or rules out MS.
- #21https://www.polradiol.com/The-diagnosis-of-multiple-sclerosis-what-has-changed-in-diagnostic-criteria-,175241,0,2.html
Beginning with the first Mc Donald criteria published in 2001, and through further revisions, we can observe the care and attention paid to clarify the guidelines and to facilitate earlier and proper diagnosis. […] The aim of this review is to analyse the McDonald criteria from 2017 and compare them with the criteria from 2010, to present the newest recommendations of the Polish Medical Society of Radiology and the Polish Society of Neurology, MAGNIMS-CMSC-NAIMS, and to demonstrate new fields for research. […] The McDonald 2017 criteria include the presence oligoclonal bands in CSF in the absence of atypical findings of CSF as a fulfilment of DIT, which practically means that in patients with CIS fulfilling the DIS criteria, the presence of CSF oligoclonal bands is sufficient for a diagnosis of MS even with no other evidence (clinical or radiological) of DIT.
- #22 Learn About Multiple Sclerosis | Shepherd Centerhttps://shepherd.org/treatment/conditions/multiple-sclerosis/overview/
An Evoked potential (EP) test records the nervous systemâs electrical response to stimulation to isolated sensory pathways such as visual, auditory, or general sensory. Because slowed response time results from damage to myelin, EPs can often find the existence of scarring along nerve pathways, something neurological exams may miss. Visual evoked potentials are found to be most useful in confirming MS diagnosis. […] A spinal tap can reveal whether you have any antibodies linked to MS. It can also work like a blood test to rule out other diseases and infections that cause similar symptoms. […] While there are no definitive blood tests for diagnosing MS, they can rule out other conditions that may mimic MS symptoms, including Lyme disease, collagen-vascular diseases, rare hereditary disorders, and acquired immune deficiency syndrome (AIDS).
- #23 Learn About Multiple Sclerosis | Shepherd Centerhttps://shepherd.org/treatment/conditions/multiple-sclerosis/overview/
An Evoked potential (EP) test records the nervous systemâs electrical response to stimulation to isolated sensory pathways such as visual, auditory, or general sensory. Because slowed response time results from damage to myelin, EPs can often find the existence of scarring along nerve pathways, something neurological exams may miss. Visual evoked potentials are found to be most useful in confirming MS diagnosis. […] A spinal tap can reveal whether you have any antibodies linked to MS. It can also work like a blood test to rule out other diseases and infections that cause similar symptoms. […] While there are no definitive blood tests for diagnosing MS, they can rule out other conditions that may mimic MS symptoms, including Lyme disease, collagen-vascular diseases, rare hereditary disorders, and acquired immune deficiency syndrome (AIDS).
- #24 Multiple Sclerosis (MS) – Neurologic Disorders – Merck Manual Professional Editionhttps://www.merckmanuals.com/professional/neurologic-disorders/demyelinating-disorders/multiple-sclerosis-ms
Separation (dissemination) in space can be established by finding lesions in 2 of the 5 following CNS areas typically affected by MS: Periventricular: 3 lesions, Cortical/juxtacortical (white matter next to cortex and/or cortex): 1 lesions, Infratentorial: 1 lesions, Spinal cord: 1 lesions, Optic nerve: 1 lesions (either by MRI or clinical evaluation). […] If MRI plus clinical findings are not diagnostic, additional testing may be necessary to objectively demonstrate separate neurologic abnormalities. Such testing may include evoked potentials and, occasionally, CSF examination or blood tests. […] Evoked potentials (delays in electrical responses to sensory stimulation) are often more sensitive for MS than symptoms or signs. Visual evoked responses are sensitive and particularly helpful in patients with no confirmed cranial lesions (eg, those with lesions only in the spinal cord). Somatosensory evoked potentials and brain stem auditory evoked potentials are sometimes also measured.
- #25 Multiple Sclerosis (MS) – Neurologic Disorders – Merck Manual Professional Editionhttps://www.merckmanuals.com/professional/neurologic-disorders/demyelinating-disorders/multiple-sclerosis-ms
Separation (dissemination) in space can be established by finding lesions in 2 of the 5 following CNS areas typically affected by MS: Periventricular: 3 lesions, Cortical/juxtacortical (white matter next to cortex and/or cortex): 1 lesions, Infratentorial: 1 lesions, Spinal cord: 1 lesions, Optic nerve: 1 lesions (either by MRI or clinical evaluation). […] If MRI plus clinical findings are not diagnostic, additional testing may be necessary to objectively demonstrate separate neurologic abnormalities. Such testing may include evoked potentials and, occasionally, CSF examination or blood tests. […] Evoked potentials (delays in electrical responses to sensory stimulation) are often more sensitive for MS than symptoms or signs. Visual evoked responses are sensitive and particularly helpful in patients with no confirmed cranial lesions (eg, those with lesions only in the spinal cord). Somatosensory evoked potentials and brain stem auditory evoked potentials are sometimes also measured.
- #26 Blood Work for Diagnosing Multiple Sclerosis (MS)https://www.healthline.com/health/multiple-sclerosis/blood-tests
Blood tests are often the first line of testing for evaluating MS symptoms. They cant confirm a diagnosis of MS, but they can help rule out other conditions or point to a diagnosis. […] Blood tests help to rule out or confirm other health conditions with symptoms similar to those of MS. Often, other tests, such as an MRI, a spinal tap, or evoked potential exams, are also part of the diagnostic process. […] Generally, a series of tests are needed to rule out other potential conditions and meet the criteria for diagnosis of MS. […] In addition to gathering symptom history and blood tests, your doctor might also order the following tests. […] An MRI is painless, noninvasive, and can produce detailed images of the brain and spinal cord. […] Although lumbar puncture cant rule out or confirm MS, it can help with diagnosis.
- #27 Multiple Sclerosis: Diagnosis & Treatment | NewYork-Presbyterianhttps://www.nyp.org/neuro/multiple-sclerosis/treatment
How is Multiple Sclerosis (MS) Diagnosed? Diagnosis Multiple sclerosis (MS) cannot be diagnosed through one test alone. A diagnosis requires a neurologist to thoroughly evaluate a patients symptoms and other tests to rule out any other conditions that may be causing symptoms. […] The neurologist will perform a physical examination and assess the frequency of symptoms. They may also conduct a neurological exam and other tests, such as an MRI, blood tests, or a spinal tap, to determine a diagnosis. […] MRI – A magnetic field and radio waves are used to generate a detailed image of the brain, allowing a doctor to see lesions (new areas of damage) that have formed on the brain and spinal cord […] Blood tests – Although blood tests cannot conclusively determine if you have MS, they can rule out other conditions that may be causing symptoms.
- #28 Learn About Multiple Sclerosis | Shepherd Centerhttps://shepherd.org/treatment/conditions/multiple-sclerosis/overview/
An Evoked potential (EP) test records the nervous systemâs electrical response to stimulation to isolated sensory pathways such as visual, auditory, or general sensory. Because slowed response time results from damage to myelin, EPs can often find the existence of scarring along nerve pathways, something neurological exams may miss. Visual evoked potentials are found to be most useful in confirming MS diagnosis. […] A spinal tap can reveal whether you have any antibodies linked to MS. It can also work like a blood test to rule out other diseases and infections that cause similar symptoms. […] While there are no definitive blood tests for diagnosing MS, they can rule out other conditions that may mimic MS symptoms, including Lyme disease, collagen-vascular diseases, rare hereditary disorders, and acquired immune deficiency syndrome (AIDS).
- #29 Getting the Diagnosis Right With Multiple Sclerosis | Cedars-Sinaihttps://www.cedars-sinai.org/blog/getting-ms-diagnosis-right.html
„The main risk is that the disease goes on to be uncontrolled for longer when it doesn’t have to be,” Al-Louzi said. „If we were accurate in diagnosing it early, we can initiate effective therapies that match the patient’s risk profile and effectively control the disease.” […] Given these challenges to accurate, early diagnosis, researchers at Cedars-Sinai are focused on developing new, more precise diagnostic tools targeting MS. […] „This marker of whether lesions develop around veins and venules in the brain is highly specific for MS, and it can help us confirm the diagnosis compared to other conventional methods,” Al-Louzi said. […] „We’re seeing very encouraging data that the presence of those lesions at the initial scan can help us make a diagnosis of MS when combined with other clinical and radiological features,” Al-Louzi said.
- #30 Learn About Multiple Sclerosis | Shepherd Centerhttps://shepherd.org/treatment/conditions/multiple-sclerosis/overview/
The first step in diagnosing the disease is thoroughly reviewing your medical history. During this time, your healthcare provider will gather information about birthplace, family history, environmental exposures, and other illnesses that may meet any risk factors for MS. […] Along with your medical history, a physical and neurological exam is used to confirm MS symptoms while testing the nerves that control your vision, strength, and hearing. […] The medical history and exam can often provide enough evidence to meet the diagnostic criteria. However, additional testing may be necessary to confirm the diagnosis further or rule out other conditions that may cause symptoms like MS. […] An MRI is the best imaging technology to detect scarring or MS plaques in different parts of the central nervous system (CNS). This test can also distinguish old MS plaques from those currently active or new ones.
- #31 Learn About Multiple Sclerosis | Shepherd Centerhttps://shepherd.org/treatment/conditions/multiple-sclerosis/overview/
The first step in diagnosing the disease is thoroughly reviewing your medical history. During this time, your healthcare provider will gather information about birthplace, family history, environmental exposures, and other illnesses that may meet any risk factors for MS. […] Along with your medical history, a physical and neurological exam is used to confirm MS symptoms while testing the nerves that control your vision, strength, and hearing. […] The medical history and exam can often provide enough evidence to meet the diagnostic criteria. However, additional testing may be necessary to confirm the diagnosis further or rule out other conditions that may cause symptoms like MS. […] An MRI is the best imaging technology to detect scarring or MS plaques in different parts of the central nervous system (CNS). This test can also distinguish old MS plaques from those currently active or new ones.
- #32 How Is Multiple Sclerosis Diagnosed? | National MS SocietyNational Multiple Sclerosis Society LogoNational Multiple Sclerosis Society LogoOpen searchhttps://www.nationalmssociety.org/understanding-ms/what-is-ms/how-ms-is-diagnosed
To diagnose MS, healthcare providers must first exclude other causes. They do this using the tools and tests outlined above. This process of exclusion may be quick for some. More often, it can take much longer and involve repeat testing to look for changes. Diagnosing MS as quickly and accurately as possible is important for several reasons: […] We now know that permanent neurologic damage can occur even in the earliest stages of MS. Confirming the diagnosis enables you to start the appropriate treatment as early as possible.
- #33 Multiple Sclerosis Differential Diagnoseshttps://emedicine.medscape.com/article/1146199-differential
Both primary and metastatic spinal cord neoplasms must be considered in the differential diagnosis of MS. On imaging studies, the presence of cysts and hemorrhage support the diagnosis of neoplasm. […] ADEM is considered an isolated postinfectious or postvaccination autoimmune attack on the CNS that leads to diffuse demyelination. ADEM is characterized by acute onset of motor, sensory, cerebellar, and cranial nerve dysfunction with encephalopathy, progressing to coma and eventual death in 30% of cases. […] MRI of the brain may be helpful for showing additional lesions in cases of MS or ADEM. This condition usually responds to steroid therapy; therefore, a treatment trial is often considered before proceeding with biopsy. This process is typically monophasic. […] Schilder disease is characterized in children and young adolescents by massive demyelination, presenting often as asymmetrical foci (often the size of an entire lobe) in the white matter on MRI and with a malignant course (ie, deterioration over months or a few years, with cortical blindness, hemiplegia, or paraplegia).
- #34 The Radiology Assistant : Multiple Sclerosis 2.0https://radiologyassistant.nl/neuroradiology/multiple-sclerosis/diagnosis-and-differential-diagnosis-3
If a patient is clinically suspected of having MS and the MR-images support that diagnosis, then you should not consider other uncommon diseases. […] Conversely, it is not wise to put MS in the differential diagnosis if the clinician does not suspect the patient of having MS and on the MR incidental WMLs are found. […] On the other hand if a patient is clinically suspected of having MS and multiple WMLs are found, our major concern is the differential diagnosis MS versus small vessel disease. […] The differences between small vessel disease and MS are summarized in the table. […] A very important differential to keep in mind, especially in patients with a bilateral optic neuritis and myelitis, is Neuromyelitis Optica Spectrum Disorder (NMOSD), previously called Devic’s Disease. […] Acute Disseminated Encephalomyelitis (ADEM) is another important differential diagnosis of MS. […] The diagnosis of PML according to diagnostic criteria is based on the clinical presentation, the identification of JCV DNA in the CNS (e.g., in the cerebrospinal fluid) and imaging findings preferably on MRI.
- #35 Multiple Sclerosis Differential Diagnoseshttps://emedicine.medscape.com/article/1146199-differential
Bal concentric sclerosis is considered by some authors to be a variant of Schilder disease, with MRI lesions showing a characteristic alternating pattern of spared and damaged white matter that suggests progression of the disease process from the ventricles outward. […] Sarcoidosis involves the CNS in approximately 5% of cases. Concomitant pial involvement is frequently encountered. Gadolinium enhancement of the pia and white matter lesions on MRI is usually the rule. […] CADASIL is an autosomal dominant disease affecting small and middle-sized brain blood vessels and characterized by recurrent headaches and strokes or transient ischemic attacks. […] Transverse myelitis is the term usually used for idiopathic inflammatory myelopathy. […] Infarction of the spinal cord is more common at the thoracic level.
- #36 Learn About Multiple Sclerosis | Shepherd Centerhttps://shepherd.org/treatment/conditions/multiple-sclerosis/overview/
An Evoked potential (EP) test records the nervous systemâs electrical response to stimulation to isolated sensory pathways such as visual, auditory, or general sensory. Because slowed response time results from damage to myelin, EPs can often find the existence of scarring along nerve pathways, something neurological exams may miss. Visual evoked potentials are found to be most useful in confirming MS diagnosis. […] A spinal tap can reveal whether you have any antibodies linked to MS. It can also work like a blood test to rule out other diseases and infections that cause similar symptoms. […] While there are no definitive blood tests for diagnosing MS, they can rule out other conditions that may mimic MS symptoms, including Lyme disease, collagen-vascular diseases, rare hereditary disorders, and acquired immune deficiency syndrome (AIDS).
- #37 Multiple Sclerosis Differential Diagnoseshttps://emedicine.medscape.com/article/1146199-differential
Bal concentric sclerosis is considered by some authors to be a variant of Schilder disease, with MRI lesions showing a characteristic alternating pattern of spared and damaged white matter that suggests progression of the disease process from the ventricles outward. […] Sarcoidosis involves the CNS in approximately 5% of cases. Concomitant pial involvement is frequently encountered. Gadolinium enhancement of the pia and white matter lesions on MRI is usually the rule. […] CADASIL is an autosomal dominant disease affecting small and middle-sized brain blood vessels and characterized by recurrent headaches and strokes or transient ischemic attacks. […] Transverse myelitis is the term usually used for idiopathic inflammatory myelopathy. […] Infarction of the spinal cord is more common at the thoracic level.
- #38 Multiple Sclerosis Differential Diagnoseshttps://emedicine.medscape.com/article/1146199-differential
Another common problem is the presence of small T2 hyperintensities on MRI studies of the CNS, typically referred to as unidentified bright objects (UBOs) by neuroradiologists. These nonspecific lesions are relatively common in the general adult population, and clinical correlation (ie, a high degree of suspicion based on clinical evidence) becomes important in the diagnosis. To confirm MS in these cases, the physician should look for sites of involvement that are rare for UBOs but frequent for MS (eg, the corpus callosum or throughout the spinal cord). […] The main differential diagnoses for MS include, but are not limited to, the following: Spinal cord neoplasms (eg, astrocytomas, ependymomas), Acute disseminated encephalomyelitis (ADEM), Schilder disease, Bal concentric sclerosis, Sarcoidosis, Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), Transverse myelitis, Infarction of the spinal cord, Vasculitis, Radiation myelitis, Arteriovenous fistula, Progressive multifocal leukoencephalitis, Subacute combined degeneration of the spinal cord (vitamin B12 deficiency), Small-vessel ischemic disease (affecting the brain primarily, and caused by diseases with vascular risk factors, such as diabetes, hypertension, hyperlipidemia, old age).
- #39 Multiple Sclerosis Differential Diagnoseshttps://emedicine.medscape.com/article/1146199-differential
Both primary and metastatic spinal cord neoplasms must be considered in the differential diagnosis of MS. On imaging studies, the presence of cysts and hemorrhage support the diagnosis of neoplasm. […] ADEM is considered an isolated postinfectious or postvaccination autoimmune attack on the CNS that leads to diffuse demyelination. ADEM is characterized by acute onset of motor, sensory, cerebellar, and cranial nerve dysfunction with encephalopathy, progressing to coma and eventual death in 30% of cases. […] MRI of the brain may be helpful for showing additional lesions in cases of MS or ADEM. This condition usually responds to steroid therapy; therefore, a treatment trial is often considered before proceeding with biopsy. This process is typically monophasic. […] Schilder disease is characterized in children and young adolescents by massive demyelination, presenting often as asymmetrical foci (often the size of an entire lobe) in the white matter on MRI and with a malignant course (ie, deterioration over months or a few years, with cortical blindness, hemiplegia, or paraplegia).
- #40 Getting the Diagnosis Right With Multiple Sclerosis | Cedars-Sinaihttps://www.cedars-sinai.org/blog/getting-ms-diagnosis-right.html
Nearly one in five patients with an established diagnosis of multiple sclerosis (MS) are misdiagnosed, according to a 2019 study led by Cedars-Sinai. […] „We need more education on why it’s not and how people get the diagnosis wrong.” […] „A big problem in MS is we have a lot of tools that detect everyone who may have MS but also lump in people with other conditions that are not MS,” Kaisey said. „We don’t yet have tools that will identify only MS. We have sensitive markers but not specific markers to distinguish MS from other diagnoses.” […] „Sometimes, patients who are misdiagnosed with MS are placed on MS therapies that alter or suppress the immune system. This can put patients who don’t have MS at a higher risk of side effects, including infection.” […] Misdiagnosis holds critical consequences for patients’ health, which is why the Cedars MS and Neuroimmunology program, led by Nancy Sicotte, MD, has been focused on developing and utilizing novel diagnostic biomarkers.
- #41 Multiple Sclerosis (MS) Diagnosis: How Doctors Test for MShttps://www.webmd.com/multiple-sclerosis/multiple-sclerosis-diagnosing
There’s no single test that can tell whether you have multiple sclerosis (MS), so it may take some time and multiple doctor visits to get a diagnosis. Doctors use a combination of physical exams, medical history questions, imaging tests, and laboratory tests to diagnose the condition. […] Your doctor may suspect you have MS if you have symptoms like: Numbness or tingling in your skin (usually in your hands or feet), Unusual weakness in your arms, legs, or fingers, Slurred speech, Stumbling or trouble walking, Double vision or loss of color, Flashing lights that others can’t see, Eye pain that gets worse when you move. […] If your symptoms, medical history, and physical exam results point to MS, your doctor can order one or more tests to help them tell whether your brain and spinal cord are working as they should.
- #42 Signs of Multiple Sclerosis Show Up in Blood Years Before Symptoms Appear | UC San Franciscohttps://www.ucsf.edu/news/2024/04/427436/signs-multiple-sclerosis-show-blood-years-symptoms-appear
In a discovery that could hasten treatment for patients with multiple sclerosis (MS), UC San Francisco scientists have discovered a harbinger in the blood of some people who later went on to develop the disease. […] In about 1 in 10 cases of MS, the body begins producing a distinctive set of antibodies against its own proteins years before symptoms emerge. […] The scientists hope the autoantibodies they have discovered will one day be detected with a simple blood test, giving patients a head start on receiving treatment. […] A diagnostic result like this makes such early intervention more likely, giving patients hope for a better life. […] MS affects more than 900,000 people in the US. Its early symptoms, like dizziness, spasms, and fatigue, can resemble other conditions, and diagnosis requires careful analysis of brain MRI scans.
- #43 How is MS diagnosed? | Testing for MS | Multiple Sclerosis News TodayEnvelope iconhttps://multiplesclerosisnewstoday.com/multiple-sclerosis-diagnosis/
About 20% of people with MS will experience optic neuritis, or inflammation of the nerves that connect the eyes to the brain, as their first symptom. […] A variety of other clinical and laboratory tests may be used to diagnose MS. […] According to the National MS Society, before confirming an MS diagnosis, other conditions with similar manifestations must be ruled out. […] MS is usually diagnosed between the ages of 20 and 50, but it can go undetected for years. […] The symptoms of MS can vary considerably between patients, as well as over time, making the diagnosis difficult. […] Given that a misdiagnosis of MS could put a person at risk of receiving unnecessary treatment, healthcare professionals usually are careful, and meticulous in their assessments, before making a final diagnosis of the disease.
- #44 Diagnosing Multiple Sclerosis Using the McDonald Criteria – Multiple Sclerosis Centers of Excellencehttps://www.va.gov/MS/Professionals/diagnosis/Diagnosing_MS_Using_the_McDonald_Criteria.asp
Clinically Isolated Syndrome (CIS) is a term that describes an isolated episode of neurological symptoms caused by inflammatory disease of the brain or spinal cord that do not meet 2017 McDonald criteria for MS (Brownlee 2014). CIS can be monofocal, meaning a single symptom such as vision loss from optic neuritis, or multifocal due to lesions in several locations. […] In diagnosing CIS, the physician faces two challenges: first, to determine whether the persons symptoms are cause by CNS inflammation and not another process, and second, to determine the likelihood that a person experiencing this type of demyelinating event is going to develop MS. A person with CIS has a higher risk (70-80%) of developing MS when the CIS is accompanied by MRI-detected brain lesions that are similar to those seen in MS (i.e. typical lesions). Conversely, there is a lower risk (20-30%) for MS when the MRI does not show brain lesions. A radiologist or neurologist trained in examining lesions is helpful in determining if lesions, if present, are typical of MS.
- #45 Multiple Sclerosis Differential Diagnoseshttps://emedicine.medscape.com/article/1146199-differential
Another common problem is the presence of small T2 hyperintensities on MRI studies of the CNS, typically referred to as unidentified bright objects (UBOs) by neuroradiologists. These nonspecific lesions are relatively common in the general adult population, and clinical correlation (ie, a high degree of suspicion based on clinical evidence) becomes important in the diagnosis. To confirm MS in these cases, the physician should look for sites of involvement that are rare for UBOs but frequent for MS (eg, the corpus callosum or throughout the spinal cord). […] The main differential diagnoses for MS include, but are not limited to, the following: Spinal cord neoplasms (eg, astrocytomas, ependymomas), Acute disseminated encephalomyelitis (ADEM), Schilder disease, Bal concentric sclerosis, Sarcoidosis, Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), Transverse myelitis, Infarction of the spinal cord, Vasculitis, Radiation myelitis, Arteriovenous fistula, Progressive multifocal leukoencephalitis, Subacute combined degeneration of the spinal cord (vitamin B12 deficiency), Small-vessel ischemic disease (affecting the brain primarily, and caused by diseases with vascular risk factors, such as diabetes, hypertension, hyperlipidemia, old age).
- #46 A Practical Guide to Diagnosing & Undiagnosing Multiple Sclerosis – The Neurology Hubhttps://theneurologyhub.com/article/a-practical-guide-to-diagnosing-undiagnosing-multiple-sclerosis
Misdiagnosis of multiple sclerosis (MS) is common and occurs chiefly for 1 of the following 5 reasons: 1. There is no pathognomonic clinical feature or diagnostic test for MS; 2. The differential diagnosis includes a long list of conditions that can be credibly mistaken for MS; 3. The clinical presentations of MS are variable; 4. MS is not common enough for extensive experience with it to accumulate outside specialized centers; and 5. There is pressure to diagnose MS quickly in order to initiate disease-modifying therapy (DMT) early to forestall relapses and long-term disability. […] […] Despite the accepted McDonald Criteria for MS diagnosis addressing the possibility of misdiagnosis and suggesting strategies to mitigate that risk, the rate of MS misdiagnosis remains high and may even be rising. A recent study suggested almost 20% of people referred to MS clinics with a diagnosis of MS did not actually have the disease. […]
- #47 Getting the Diagnosis Right With Multiple Sclerosis | Cedars-Sinaihttps://www.cedars-sinai.org/blog/getting-ms-diagnosis-right.html
Nearly one in five patients with an established diagnosis of multiple sclerosis (MS) are misdiagnosed, according to a 2019 study led by Cedars-Sinai. […] „We need more education on why it’s not and how people get the diagnosis wrong.” […] „A big problem in MS is we have a lot of tools that detect everyone who may have MS but also lump in people with other conditions that are not MS,” Kaisey said. „We don’t yet have tools that will identify only MS. We have sensitive markers but not specific markers to distinguish MS from other diagnoses.” […] „Sometimes, patients who are misdiagnosed with MS are placed on MS therapies that alter or suppress the immune system. This can put patients who don’t have MS at a higher risk of side effects, including infection.” […] Misdiagnosis holds critical consequences for patients’ health, which is why the Cedars MS and Neuroimmunology program, led by Nancy Sicotte, MD, has been focused on developing and utilizing novel diagnostic biomarkers.
- #48 A Practical Guide to Diagnosing & Undiagnosing Multiple Sclerosis – The Neurology Hubhttps://theneurologyhub.com/article/a-practical-guide-to-diagnosing-undiagnosing-multiple-sclerosis
A challenge with implementing the diagnostic criteria is that they should be applied to patients who have experienced a monophasic clinical episode. This presupposes expertise in recognizing typical MS relapses, which is generally the hardest part of the diagnostic process. […] […] Use of the criteria also requires knowledge of size, location, and morphology of demyelinating lesions on MRI. In practice, misclassification of nonspecific vs demyelinating lesions on brain MRI is a leading contributor to MS misdiagnosis. […] […] It is likely that incorporation of the more specific radiographic signs of demyelination into the diagnostic criteria, such as the central vein sign or paramagnetic rims, will greatly decrease the risk of MRI-supported MS misdiagnosis. Recognition of these signs, however, requires optimization of MRI sequences not yet available outside of a few specialized centers. […]
- #49 Getting the Diagnosis Right With Multiple Sclerosis | Cedars-Sinaihttps://www.cedars-sinai.org/blog/getting-ms-diagnosis-right.html
„The main risk is that the disease goes on to be uncontrolled for longer when it doesn’t have to be,” Al-Louzi said. „If we were accurate in diagnosing it early, we can initiate effective therapies that match the patient’s risk profile and effectively control the disease.” […] Given these challenges to accurate, early diagnosis, researchers at Cedars-Sinai are focused on developing new, more precise diagnostic tools targeting MS. […] „This marker of whether lesions develop around veins and venules in the brain is highly specific for MS, and it can help us confirm the diagnosis compared to other conventional methods,” Al-Louzi said. […] „We’re seeing very encouraging data that the presence of those lesions at the initial scan can help us make a diagnosis of MS when combined with other clinical and radiological features,” Al-Louzi said.
- #50 How is MS Diagnosed? – Multiple Sclerosis Centerhttps://www.uab.edu/mscenter/resources/about-ms/how-is-ms-diagnosed
While standard MRI provides an anatomical picture of lesions, magnetic resonance spectroscopy (MRS) yields information about the brain’s biochemistry; specifically, it can measure the brain chemical N-acetyl aspartate. […] In addition to helping scientists and physicians better understand how MS develops-an important first step in devising new treatments-these approaches offer earlier diagnosis and enhance efforts to monitor disease progression and the effects of treatment.
- #51 How is MS diagnosed? – MS Australiahttps://www.msaustralia.org.au/how-is-ms-diagnosed/
Globally, there are continuing research efforts to help clinicians arrive at a diagnosis of MS as quickly and accurately as possible. MRI scanning and analysis techniques are constantly being improved. But the Holy Grail is a blood test that could swiftly confirm a diagnosis of MS. To date, while many markers in the blood have been examined and some have shown promise, there is no single blood test that can confirm MS.
- #52 A Blood Test for the Diagnosis of Multiple Sclerosishttps://www.mdpi.com/1422-0067/25/3/1696
Clinicians following these criteria are reminded to consider alternative diagnoses. […] Hence, blood markers emerge as particularly attractive options for their ease of sampling; numerous biomarkers show promise for serving as diagnostic markers for MS. […] The results disclosed in this manuscript were acquired through in-house assays, and additional steps are required before achieving a fully validated diagnostic product. […] The major finding in the present study is that our ELISA test, using a simple blood sample, can detect the presence of MS specific auto-Ab, with a sensitivity and specificity above 95%. […] To date, the laboratory tests commercially available for the diagnosis of multiple sclerosis include the measurement of Free Kappa Light Chains (kFLC) and the quantification of Neurofilament Light Chains (NfL) and Glial Fibrillary Acid Protein (GFAP) levels.
- #53 A Blood Test for the Diagnosis of Multiple Sclerosishttps://www.mdpi.com/1422-0067/25/3/1696
Clinicians following these criteria are reminded to consider alternative diagnoses. […] Hence, blood markers emerge as particularly attractive options for their ease of sampling; numerous biomarkers show promise for serving as diagnostic markers for MS. […] The results disclosed in this manuscript were acquired through in-house assays, and additional steps are required before achieving a fully validated diagnostic product. […] The major finding in the present study is that our ELISA test, using a simple blood sample, can detect the presence of MS specific auto-Ab, with a sensitivity and specificity above 95%. […] To date, the laboratory tests commercially available for the diagnosis of multiple sclerosis include the measurement of Free Kappa Light Chains (kFLC) and the quantification of Neurofilament Light Chains (NfL) and Glial Fibrillary Acid Protein (GFAP) levels.
- #54 A Blood Test for the Diagnosis of Multiple Sclerosishttps://www.mdpi.com/1422-0067/25/3/1696
Multiple sclerosis (MS) is an autoimmune chronic disease characterized by inflammation and demyelination of the central nervous system (CNS). […] Despite numerous studies conducted, valid biomarkers enabling a definitive diagnosis of MS are not yet available. […] The aim of our study was to identify a marker from a blood sample to ease the diagnosis of MS. […] The results show that in the serum of patients with MS there are auto-Ab against the serotonin receptor type 2A which can be successfully used in the diagnosis of MS due to their high sensitivity and specificity. […] A prompt diagnosis of MS allows for early therapeutic intervention, improving disease progression, reducing patient suffering, and lowering financial costs for both patients and the healthcare system. […] The criteria for diagnosing MS have undergone multiple revisions, with the current McDonald criteria relying heavily on magnetic resonance imaging (MRI).
- #55 Could a Blood Test Revolutionize Multiple Sclerosis Diagnosis?https://news.cuanschutz.edu/news-stories/could-a-blood-test-revolutionize-multiple-sclerosis-diagnosis
CU researchers discovered that a blood test can identify MS biomarkers with 90% accuracy, offering a path to monitoring patient response to different therapies and informing future treatment decisions, and the prediction of disease progression. […] A simple blood test into multiple sclerosis (MS) pathology could speed MS diagnostics and ultimately improve patient care, according to Xiaoli Yu, PhD, senior author of a new study on plasma immunoglobulin G (IgG) antibody aggregates. […] The blood test study shows, however, that its possible to detect MS at early stages with strong accuracy, Yu said. […] Importantly, we also showed that you can make a prognosis for disease progression, she said. We saw that SPMS patients had higher amounts of the antibodies so there is a strong correlation (between antibody biomarkers and disease progression).
- #56 Signs of Multiple Sclerosis Show Up in Blood Years Before Symptoms Appear | UC San Franciscohttps://www.ucsf.edu/news/2024/04/427436/signs-multiple-sclerosis-show-blood-years-symptoms-appear
In a discovery that could hasten treatment for patients with multiple sclerosis (MS), UC San Francisco scientists have discovered a harbinger in the blood of some people who later went on to develop the disease. […] In about 1 in 10 cases of MS, the body begins producing a distinctive set of antibodies against its own proteins years before symptoms emerge. […] The scientists hope the autoantibodies they have discovered will one day be detected with a simple blood test, giving patients a head start on receiving treatment. […] A diagnostic result like this makes such early intervention more likely, giving patients hope for a better life. […] MS affects more than 900,000 people in the US. Its early symptoms, like dizziness, spasms, and fatigue, can resemble other conditions, and diagnosis requires careful analysis of brain MRI scans.
- #57 Signs of Multiple Sclerosis Show Up in Blood Years Before Symptoms Appear | UC San Franciscohttps://www.ucsf.edu/news/2024/04/427436/signs-multiple-sclerosis-show-blood-years-symptoms-appear
The group analyzed blood from 250 MS patients collected after their diagnosis, plus samples taken five or more years earlier when they joined the military. […] Instead, they found that 10% of the MS patients had a striking abundance of autoantibodies years before their diagnosis. […] The pattern was 100% predictive of an MS diagnosis. […] Diagnosis is not always straightforward for MS, because we haven’t had disease specific biomarkers, Wilson said. […] Many questions remain about MS, ranging from what’s instigating the immune response in some MS patients to how the disease develops in the other 90% of patients. […] But the researchers believe they now have a definitive sign that MS is brewing. […] Imagine if we could diagnose MS before some patients reach the clinic, said Stephen Hauser, MD, director of the UCSF Weill Institute for Neurosciences and a senior author of the paper.
- #58 Multiple sclerosis – Symptoms and causes – Mayo Clinichttps://www.mayoclinic.org/diseases-conditions/multiple-sclerosis/symptoms-causes/syc-20350269
There’s currently no single test to make a diagnosis of MS. However, there are four key features which help to secure the diagnosis. Firstly, are there typical symptoms of multiple sclerosis? Again, those are loss of vision in an eye, loss of power in an arm or leg, or sensory disturbance in an arm or leg lasting for more than 24 hours. […] Secondly, do you have any physical examination findings consistent with MS? Next, is the MRI of your brain or spine consistent with MS? Now here it’s important to note that 95 percent of people over the age of 40 have an abnormal brain MRI, just the same as many of us have wrinkles on our skin. Lastly, are the results of the spinal fluid analysis consistent with MS? Your doctor may recommend blood tests to check for other diseases that share the same symptoms. They may also recommend an OCT test or optical coherence tomography. This is a short scan of the thickness of the layers at the back of your eye. […] There’s no cure for multiple sclerosis. However, there are treatments to help speed the recovery from attacks, modify the course of the disease and manage symptoms.
- #59 Multiple Sclerosis: Causes, Symptoms, & Diagnosishttps://www.webmd.com/multiple-sclerosis/what-is-multiple-sclerosis
A test that makes detailed pictures of the structures in your body (specifically your brain or spinal cord), called an MRI. […] Analysis of cerebrospinal fluid (CSF), the liquid that cushions your brain and spinal cord. This will be done through a lumbar puncture or spinal tap. People with MS usually have specific proteins in their CSF. […] Optical coherence tomography (OCT), a test used to detect changes in the retina, which could warn of brain atrophy.
- #60 How Is Multiple Sclerosis Diagnosed? | National MS SocietyNational Multiple Sclerosis Society LogoNational Multiple Sclerosis Society LogoOpen searchhttps://www.nationalmssociety.org/understanding-ms/what-is-ms/how-ms-is-diagnosed
To diagnose MS, healthcare providers must first exclude other causes. They do this using the tools and tests outlined above. This process of exclusion may be quick for some. More often, it can take much longer and involve repeat testing to look for changes. Diagnosing MS as quickly and accurately as possible is important for several reasons: […] We now know that permanent neurologic damage can occur even in the earliest stages of MS. Confirming the diagnosis enables you to start the appropriate treatment as early as possible.
- #61 A Blood Test for the Diagnosis of Multiple Sclerosishttps://www.mdpi.com/1422-0067/25/3/1696
The blood test we have described can be complementarily employed alongside clinical examinations and instrumental diagnostics such as MRI and evoked potentials. […] This integration has the potential to streamline and enhance the treatment approach for MS. […] Achieving an early and accurate diagnosis of multiple sclerosis is crucial, as numerous studies have demonstrated that initiating therapy with Disease-Modifying Therapies (DMTs) at an early stage significantly reduces the frequency and severity of relapses in MS patients compared to delayed treatment. […] The results presented in this study are available on request from the corresponding author.
- #62 The Diagnosis of Multiple Sclerosis | Journal of Ethics | American Medical Associationhttps://journalofethics.ama-assn.org/article/diagnosis-multiple-sclerosis/2006-02
The push to make an earlier diagnosis can be linked to 2 main issues. An early accurate diagnosis may help reduce the uncertainty for patients and allow them to gain access to available resources. The second, and more controversial, issue is that current data suggests that available therapeutic regimens may alter the early course of the disease and delay the development of MS.
- #63 The Diagnosis of Multiple Sclerosis | Journal of Ethics | American Medical Associationhttps://journalofethics.ama-assn.org/article/diagnosis-multiple-sclerosis/2006-02
The push to make an earlier diagnosis can be linked to 2 main issues. An early accurate diagnosis may help reduce the uncertainty for patients and allow them to gain access to available resources. The second, and more controversial, issue is that current data suggests that available therapeutic regimens may alter the early course of the disease and delay the development of MS.
- #64 Learn About Multiple Sclerosis | Shepherd Centerhttps://shepherd.org/treatment/conditions/multiple-sclerosis/overview/
Multiple sclerosis (MS) cannot be diagnosed with a specific symptom or single lab test. Instead, physicians rely on several strategies and diagnostic tests to confidently make a diagnosis and rule out other possible conditions. Diagnosing MS quickly and accurately is important as neurologic damage can occur in the early stages of MS. […] A set of diagnostic parameters, known as the McDonald Criteria, makes the process easier and more efficient in diagnosing MS in new patients. To fulfill a definite diagnosis of MS, an individual must have met the following criteria: Evidence of damage in at least two separate areas of the central nervous system (CNS), including the brain, spinal cord, and optic nerves. Evidence of damage occurring at least one month apart. All other possible diagnoses have been ruled out.
- #65 Multiple Sclerosis (MS): What It Is, Symptoms & Treatmenthttps://my.clevelandclinic.org/health/diseases/17248-multiple-sclerosis
There isnt a single diagnostic tool available to pinpoint the condition. Instead, a provider will diagnose MS after a physical exam, a neurological exam and testing. […] During an exam, your provider will learn more about your symptoms and medical history. Testing may include blood work, MRIs of your brain and spinal cord, and an analysis of your spinal fluid. […] It can take time before you receive an official MS diagnosis. You may need to make several trips to see your provider before you know for sure. This happens because MS symptoms can look like or happen with several other common conditions. While the delay in an official diagnosis can be frustrating, getting the right diagnosis helps your provider accurately treat your symptoms. […] Diagnostic testing helps your provider rule out conditions with similar symptoms to MS. Testing may include: Blood tests and urine tests, Magnetic resonance imaging test (MRI), Optical coherence tomography (OCT) test, Lumbar puncture, Evoked potential (EP) test. […] If your primary care provider suspects you may have MS, they may refer you to see a neurologist. A neurologist is a doctor who specializes in treating conditions that affect the nervous system, which includes your brain and spinal cord.
- #66 Multiple Sclerosis: Test Performed & How is it Diagnosed?https://www.clevelandclinicabudhabi.ae/en/health-hub/health-resource/diseases-and-conditions/how-is-multiple-sclerosis-diagnosed
There is no single diagnostic test that is proof-positive for multiple sclerosis. There is a set of accepted criteria for MS diagnosis, but even this system is imperfect. Since diagnosing MS can be very difficult, it must be done by a neurologist who specializes in treating MS. As many as 10% of people diagnosed with multiple sclerosis actually have some other condition that mimics MS. […] An accurate diagnosis is based on your medical history and neurological examination using tests of nervous system function. Much depends on the skill of the doctor in asking the right questions to uncover information and to properly evaluate the signs and symptoms of a malfunctioning nervous system. […] In addition to a thorough medical history and neurological examination, a variety of specialized procedures are helpful — although not always necessary – in accurately diagnosing MS. These include imaging techniques such as magnetic resonance imaging (MRI), spinal taps (examination of the cerebrospinal fluid that runs through the spinal column), evoked potentials (electrical tests to determine if MS affects nerve pathways), and laboratory analysis of blood samples.
- #67 Understanding Multiple Sclerosis: Symptoms, Diagnosis, and Treatment Optionshttps://www.ouhealth.com/blog/2025/march/understanding-multiple-sclerosis-symptoms-diagno/
Multiple Sclerosis (MS) is a common autoimmune disease that affects the brain and spinal cord. The journey to diagnosis can be challenging because each case is unique. […] Diagnosing MS involves a combination of physical and neurological exams, along with various tests. Your healthcare provider will review your symptoms and medical history. Tests may include blood work, MRIs of the brain and spinal cord, and spinal fluid analysis. […] Receiving an official MS diagnosis can take time and may require multiple visits to your provider. This is because MS symptoms can resemble those of other conditions. Although the wait can be nerve-wracking, an accurate diagnosis is essential for effective treatment.